跳至主要内容
临床试验/NCT01308372
NCT01308372已完成不适用

Cardiovascular Risk in General Practice in France

AstraZeneca1 个研究点 分布在 1 个国家目标入组 9,246 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
9,246
试验地点
1
主要终点
Evaluation of cardiovascular risk in general practice in France estimated by the SCORE scale

研究概览

简要总结

The purpose of this study is to evaluate the proportion of patients which present a high cardiovascular risk estimated by the SCORE scale, in general practice consultations of the 7 French regions (Paris area, North-East, Paris basin, West, South-West, South- East, Mediterranean area)

详细描述

MC MD

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Without any personal history of coronary disease
  • Non treated with lipid-lowering agents
  • Lipid test = 1 year old
  • Presenting at least one cardiovascular risk
  • Visiting their General Practitioner

排除标准

  • 未提供

结局指标

主要结局

Evaluation of cardiovascular risk in general practice in France estimated by the SCORE scale

时间窗: 1 week

次要结局

  • Evaluation of cardiovascular risk in general practice in France estimated by the Framingham 2008 scale D'Agostino(1 week)
  • Evaluation of cardiovascular risk in general practice in France estimated by the Framingham 1998 scale Wilson(1 week)
  • Evaluation of arteries age evaluation by SCORE(1 week)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Cardiovascular Risk in General Practice in France:... | 临床试验